Andriy I. Batchinsky
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Andriy I. Batchinsky has a total of 95 co-authors. Here are the top co-authors by number of shared publications:
- Teryn R. Roberts
Autonomous Reanimation and Evacuation Research Institute (AREVA), The Geneva Foundation , San Antonio, TX 78235
7 shared publications - George T. Harea
Autonomous Reanimation and Evacuation Research Institute (AREVA), The Geneva Foundation , San Antonio, TX 78235
3 shared publications Leopoldo C. Cancio
United States Army Institute of Surgical Research, JBSA Fort Sam Houston, Texas
3 shared publicationsKevin K. Chung
2 shared publications- Lawrence A. Renna
Battery Systems, Fisker Inc., Los Angeles, California, United States of America
2 shared publications - Yanyi Zang
Autonomous Reanimation and Evacuation Research Institute, The Geneva Foundation, San Antonio, TX 78235
2 shared publications
Latest Publications
- 30 October 2026
- Published by SAGE Publications in Urologia Journal
Management of complex combat-related pelvic organ injuries: Case series and review of complications
Pelvic organ injuries in combat conditions are relatively uncommon but are associated with a high risk of complications, particularly urinary injuries combined with pelvic fractures, vascular trauma, and other abdominal injuries in the setting of polytrauma. The provision of effective medical care in modern conflicts is complicated by logistical constraints, including delayed evacuation, limited imaging capabilities, and shortages of specialized personnel. This study analyzes diagnosis, treatment, and complications of combat-related urinary injuries and identifies approaches to optimize medical care. A series of clinical cases was reviewed, including five patients treated at various stages of medical evacuation. Diagnostic strategies, surgical tactics, complications, and outcomes were evaluated. Challenges included delayed diagnosis, underestimation of injury severity, unjustified conservative management of intraperitoneal ruptures, technical shortcomings in bladder repair, and insufficient interdisciplinary coordination. Complications such as urinary extravasation, peritonitis, infection, and secondary fistula formation were observed. Favorable outcomes were associated with timely injury recognition, urgent surgical intervention, continuity of staged evacuation, and early involvement of urological expertise. Optimization of diagnostic and treatment pathways and strengthening multidisciplinary collaboration are essential to reduce morbidity in combat-related pelvic organ injury trauma.
- 30 October 2026
- Published by SAGE Publications in Urologia Journal
Management of complex combat-related pelvic organ injuries: Case series and review of complications
Pelvic organ injuries in combat conditions are relatively uncommon but are associated with a high risk of complications, particularly urinary injuries combined with pelvic fractures, vascular trauma, and other abdominal injuries in the setting of polytrauma. The provision of effective medical care in modern conflicts is complicated by logistical constraints, including delayed evacuation, limited imaging capabilities, and shortages of specialized personnel. This study analyzes diagnosis, treatment, and complications of combat-related urinary injuries and identifies approaches to optimize medical care. A series of clinical cases was reviewed, including five patients treated at various stages of medical evacuation. Diagnostic strategies, surgical tactics, complications, and outcomes were evaluated. Challenges included delayed diagnosis, underestimation of injury severity, unjustified conservative management of intraperitoneal ruptures, technical shortcomings in bladder repair, and insufficient interdisciplinary coordination. Complications such as urinary extravasation, peritonitis, infection, and secondary fistula formation were observed. Favorable outcomes were associated with timely injury recognition, urgent surgical intervention, continuity of staged evacuation, and early involvement of urological expertise. Optimization of diagnostic and treatment pathways and strengthening multidisciplinary collaboration are essential to reduce morbidity in combat-related pelvic organ injury trauma.
- 13 February 2026
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 24 (5) , 1677-1689
von Willebrand factor dynamics in trauma managed with extracorporeal life support
- 13 February 2026
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 24 (5) , 1677-1689
von Willebrand factor dynamics in trauma managed with extracorporeal life support
- 1 September 2025
- Published by Oxford University Press (OUP) in Military Medicine
- Vol. 190 (Supplement) , 410-418
Normoxic Versus Hyperoxic Management of Blunt Traumatic Brain Injury at Ground Level and During Simulated Aeromedical Evacuation in Swine
Background: Aeromedical evacuation (AE) environments are characterized by hypobaria and may cause secondary insult to casualties with traumatic brain injury (TBI). As increased FiO2 is commonly administered to mechanically ventilated casualties during AE, it may exacerbate TBI. We hypothesized that hyperoxia at ground level and/or during simulated AE worsens neuroinflammation and neurodegeneration after mild-to-moderate blunt TBI. Materials and Methods: Female Yorkshire swine were anesthetized, mechanically ventilated, and received blunt TBI via a modified humane stunner. Animals were randomized into 1 of 4 groups (n = 8/group): Ground Normoxia (G-Norm); Ground Hyperoxia (G-Hyper); AE Normoxia (AE-Norm); and AE Hyperoxia (AE-Hyper), with AE groups placed in a hypobaric chamber for 6 hours at 8,000 ft and then managed in an ICU for 24 hours. Neuroinflammation and neurodegeneration were assessed via histological injury scores (0 = no injury, and 4 = most severe injury), as well as measurements of systemic HMGB1, S100β, GFAP, and cytokines such as IL-1β, IL-6, and IL-10 levels. In addition, we assessed hemodynamics, intracranial pressure, blood gases and chemistry, and coagulation variables. Results: TBI led to increased intracranial pressure, tachycardia, and transient hypertension with subsequent periodic fluctuations in heart rate and blood pressure. The G-Norm and G-Hyper groups had mild-to-moderate injuries (cerebrum: 2.0 and 1.75, respectively, NS; brainstem: 2.0 and 1.71, respectively, NS). The AE-Norm and AE-Hyper groups had numerically less injuries (cerebrum: 1.5 and 1.71, respectively, NS; brainstem: 0.86 and 1.25, respectively, NS). HMGB1 increased 2-fold after TBI in all 4 groups (P<.003). IL-6 increased after TBI and remained elevated relative to baseline in all groups except AE-Hyper group (P<.0001). No within or between-group differences were observed in any other variables. Conclusions: This 24-hour intent-to-treat study did not identify discernable differences in normoxic versus hyperoxic management of TBI at ground level or during AE. Future studies should evaluate exposures to hypobaria and hyperoxia over longer durations.
- 1 September 2025
- Published by Oxford University Press (OUP) in Military Medicine
- Vol. 190 (Supplement) , 410-418
Normoxic Versus Hyperoxic Management of Blunt Traumatic Brain Injury at Ground Level and During Simulated Aeromedical Evacuation in Swine
Background: Aeromedical evacuation (AE) environments are characterized by hypobaria and may cause secondary insult to casualties with traumatic brain injury (TBI). As increased FiO2 is commonly administered to mechanically ventilated casualties during AE, it may exacerbate TBI. We hypothesized that hyperoxia at ground level and/or during simulated AE worsens neuroinflammation and neurodegeneration after mild-to-moderate blunt TBI. Materials and Methods: Female Yorkshire swine were anesthetized, mechanically ventilated, and received blunt TBI via a modified humane stunner. Animals were randomized into 1 of 4 groups (n = 8/group): Ground Normoxia (G-Norm); Ground Hyperoxia (G-Hyper); AE Normoxia (AE-Norm); and AE Hyperoxia (AE-Hyper), with AE groups placed in a hypobaric chamber for 6 hours at 8,000 ft and then managed in an ICU for 24 hours. Neuroinflammation and neurodegeneration were assessed via histological injury scores (0 = no injury, and 4 = most severe injury), as well as measurements of systemic HMGB1, S100β, GFAP, and cytokines such as IL-1β, IL-6, and IL-10 levels. In addition, we assessed hemodynamics, intracranial pressure, blood gases and chemistry, and coagulation variables. Results: TBI led to increased intracranial pressure, tachycardia, and transient hypertension with subsequent periodic fluctuations in heart rate and blood pressure. The G-Norm and G-Hyper groups had mild-to-moderate injuries (cerebrum: 2.0 and 1.75, respectively, NS; brainstem: 2.0 and 1.71, respectively, NS). The AE-Norm and AE-Hyper groups had numerically less injuries (cerebrum: 1.5 and 1.71, respectively, NS; brainstem: 0.86 and 1.25, respectively, NS). HMGB1 increased 2-fold after TBI in all 4 groups (P<.003). IL-6 increased after TBI and remained elevated relative to baseline in all groups except AE-Hyper group (P<.0001). No within or between-group differences were observed in any other variables. Conclusions: This 24-hour intent-to-treat study did not identify discernable differences in normoxic versus hyperoxic management of TBI at ground level or during AE. Future studies should evaluate exposures to hypobaria and hyperoxia over longer durations.
- 19 June 2025
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 71 (10) , 849-860
Anticoagulate the Circuit, Not the Patient: Nitric Oxide Reduces Thrombus Formation During Extracorporeal Carbon Dioxide Removal
Solutions to reduce the need for systemic anticoagulation during extracorporeal life support would improve safety and utility. The study objective was to evaluate the safety and efficacy of a nitric oxide-generating extracorporeal carbon dioxide removal (ECCO2R) system without systemic anticoagulation in a translational swine model. We hypothesized that nitric oxide reduces circuit thrombosis, without untoward systemic effects. Anesthetized, mechanically ventilated swine (50–60 kg) received bicaval jugular cannulation for 72 hour venovenous ECCO2R. Control (n = 6) received a standard ECCO2R device with systemic heparinization. Treatment (n = 6) received the same device, but with nitric oxide–generating circuitry and 80 ppm nitric oxide added to sweep gas, without systemic heparinization. No between-group differences in vitals, ventilator settings, blood gases, extracorporeal gas exchange, or fluid balance occurred. In both groups, ECCO2R enabled reduction in tidal volume. Oxygenator thrombus area, quantified following dissection and imaging, was reduced in treatment (10.2 ± 1.2%) versus control (15.2 ± 1.6%) (p = 0.03). One control oxygenator occluded. No nitric oxide–related adverse effects were observed, including methemoglobinemia. Nitric oxide–enhanced ECCO2R enabled 72 hours of support without systemic anticoagulation, and without altering oxygenator performance or causing untoward systemic effects. Future studies are needed to investigate efficacy in subjects with underlying coagulopathy and/or contraindications for systemic anticoagulation.
- 19 June 2025
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 71 (10) , 849-860
Anticoagulate the Circuit, Not the Patient: Nitric Oxide Reduces Thrombus Formation During Extracorporeal Carbon Dioxide Removal
Solutions to reduce the need for systemic anticoagulation during extracorporeal life support would improve safety and utility. The study objective was to evaluate the safety and efficacy of a nitric oxide-generating extracorporeal carbon dioxide removal (ECCO2R) system without systemic anticoagulation in a translational swine model. We hypothesized that nitric oxide reduces circuit thrombosis, without untoward systemic effects. Anesthetized, mechanically ventilated swine (50–60 kg) received bicaval jugular cannulation for 72 hour venovenous ECCO2R. Control (n = 6) received a standard ECCO2R device with systemic heparinization. Treatment (n = 6) received the same device, but with nitric oxide–generating circuitry and 80 ppm nitric oxide added to sweep gas, without systemic heparinization. No between-group differences in vitals, ventilator settings, blood gases, extracorporeal gas exchange, or fluid balance occurred. In both groups, ECCO2R enabled reduction in tidal volume. Oxygenator thrombus area, quantified following dissection and imaging, was reduced in treatment (10.2 ± 1.2%) versus control (15.2 ± 1.6%) (p = 0.03). One control oxygenator occluded. No nitric oxide–related adverse effects were observed, including methemoglobinemia. Nitric oxide–enhanced ECCO2R enabled 72 hours of support without systemic anticoagulation, and without altering oxygenator performance or causing untoward systemic effects. Future studies are needed to investigate efficacy in subjects with underlying coagulopathy and/or contraindications for systemic anticoagulation.
- 4 December 2024
- Published by Wolters Kluwer Health in Journal of Trauma and Acute Care Surgery
- Vol. 98 (3) , 500-509
Immediate postinjury extracorporeal carbon dioxide removal reduces ventilator requirements and mitigates acute respiratory distress syndrome in swine
BACKGROUND: Awareness of ventilator-induced lung injury contributed to increased use of extracorporeal interventions, but not immediately after injury,before acute respiratory distress syndrome (ARDS) ensues. Our objective was to evaluate the role of venovenous extracorporeal carbon dioxide removal (ECCO2R) in management of mechanically ventilated swine with smoke inhalation injury and 40% body surface area burns. METHODS: Yorkshire swine (n = 29, 43.2 ± 0.5 kg) underwent anesthesia, instrumentation, severe smoke inhalation, and 40% body surface area burns, followed by 72 hours of round-the-clock intensive care unit care with mechanical ventilation, fluids, pressors, bronchoscopic cast removal, computer tomography scans, and arterial blood assays. Within 1 hour after injury, animals received ECCO2R with either MiniLung (Xenios AG, Heilbronn, Germany; n = 10) or Hemolung (ALung Technologies, Pittsburgh, PA; n = 10), or no ECCO2R in injured controls (INJC, n = 12). RESULTS: Immediate postinjury ECCO2R reduced minute ventilation (p < 0.001) and prevented ARDS in 37.5% of MiniLung and 11.1% of Hemolung animals. Time to ARDS (partial pressure of arterial oxygen to fraction of inspired oxygen ratio below 300) was shortest (14 ± 2.2 hours) in INJC, intermediate (21.6 ± 3.5 hours) in Hemolung (HEMO), and most delayed in MiniLung (31.1 ± 7.2 hours, p = 0.0121, log-rank test vs. INJC). Driving pressure was lower in MiniLung versus INJC (p < 0.0001) and HEMO versus INJC (p = 0.0005) at 48 hours. Extracorporeal CO2 removal reduced systemic levels of tumor necrosis factor α versus INJC. CONCLUSION: In swine with severe smoke inhalation and burns, immediate postinjury ECCO2R reduced ventilator settings, delayed or prevented ARDS, and reduced its severity. Proactive early percutaneous ECCO2R initiation via simplified, purpose-built devices should be considered as a low-maintenance lung injury management approach with significant disease modifying clinical benefit potential.
- 4 December 2024
- Published by Wolters Kluwer Health in Journal of Trauma and Acute Care Surgery
- Vol. 98 (3) , 500-509
Immediate postinjury extracorporeal carbon dioxide removal reduces ventilator requirements and mitigates acute respiratory distress syndrome in swine
BACKGROUND: Awareness of ventilator-induced lung injury contributed to increased use of extracorporeal interventions, but not immediately after injury,before acute respiratory distress syndrome (ARDS) ensues. Our objective was to evaluate the role of venovenous extracorporeal carbon dioxide removal (ECCO2R) in management of mechanically ventilated swine with smoke inhalation injury and 40% body surface area burns. METHODS: Yorkshire swine (n = 29, 43.2 ± 0.5 kg) underwent anesthesia, instrumentation, severe smoke inhalation, and 40% body surface area burns, followed by 72 hours of round-the-clock intensive care unit care with mechanical ventilation, fluids, pressors, bronchoscopic cast removal, computer tomography scans, and arterial blood assays. Within 1 hour after injury, animals received ECCO2R with either MiniLung (Xenios AG, Heilbronn, Germany; n = 10) or Hemolung (ALung Technologies, Pittsburgh, PA; n = 10), or no ECCO2R in injured controls (INJC, n = 12). RESULTS: Immediate postinjury ECCO2R reduced minute ventilation (p < 0.001) and prevented ARDS in 37.5% of MiniLung and 11.1% of Hemolung animals. Time to ARDS (partial pressure of arterial oxygen to fraction of inspired oxygen ratio below 300) was shortest (14 ± 2.2 hours) in INJC, intermediate (21.6 ± 3.5 hours) in Hemolung (HEMO), and most delayed in MiniLung (31.1 ± 7.2 hours, p = 0.0121, log-rank test vs. INJC). Driving pressure was lower in MiniLung versus INJC (p < 0.0001) and HEMO versus INJC (p = 0.0005) at 48 hours. Extracorporeal CO2 removal reduced systemic levels of tumor necrosis factor α versus INJC. CONCLUSION: In swine with severe smoke inhalation and burns, immediate postinjury ECCO2R reduced ventilator settings, delayed or prevented ARDS, and reduced its severity. Proactive early percutaneous ECCO2R initiation via simplified, purpose-built devices should be considered as a low-maintenance lung injury management approach with significant disease modifying clinical benefit potential.
- Open Access
- 12 June 2024
- Published by Springer Nature in Communications Medicine
- Vol. 4 (1) , 1-12
Digital twin mathematical models suggest individualized hemorrhagic shock resuscitation strategies
Background: Optimizing resuscitation to reduce inflammation and organ dysfunction following human trauma-associated hemorrhagic shock is a major clinical hurdle. This is limited by the short duration of pre-clinical studies and the sparsity of early data in the clinical setting. Methods: We sought to bridge this gap by linking preclinical data in a porcine model with clinical data from patients from the Prospective, Observational, Multicenter, Major Trauma Transfusion (PROMMTT) study via a three-compartment ordinary differential equation model of inflammation and coagulation. Results: The mathematical model accurately predicts physiologic, inflammatory, and laboratory measures in both the porcine model and patients, as well as the outcome and time of death in the PROMMTT cohort. Model simulation suggests that resuscitation with plasma and red blood cells outperformed resuscitation with crystalloid or plasma alone, and that earlier plasma resuscitation reduced injury severity and increased survival time. Conclusions: This workflow may serve as a translational bridge from pre-clinical to clinical studies in trauma-associated hemorrhagic shock and other complex disease settings.
- 12 June 2024
- Published by Springer Nature in Communications Medicine
- Vol. 4 (1) , 1-12
Open AccessDigital twin mathematical models suggest individualized hemorrhagic shock resuscitation strategies
Background: Optimizing resuscitation to reduce inflammation and organ dysfunction following human trauma-associated hemorrhagic shock is a major clinical hurdle. This is limited by the short duration of pre-clinical studies and the sparsity of early data in the clinical setting. Methods: We sought to bridge this gap by linking preclinical data in a porcine model with clinical data from patients from the Prospective, Observational, Multicenter, Major Trauma Transfusion (PROMMTT) study via a three-compartment ordinary differential equation model of inflammation and coagulation. Results: The mathematical model accurately predicts physiologic, inflammatory, and laboratory measures in both the porcine model and patients, as well as the outcome and time of death in the PROMMTT cohort. Model simulation suggests that resuscitation with plasma and red blood cells outperformed resuscitation with crystalloid or plasma alone, and that earlier plasma resuscitation reduced injury severity and increased survival time. Conclusions: This workflow may serve as a translational bridge from pre-clinical to clinical studies in trauma-associated hemorrhagic shock and other complex disease settings.
- 12 November 2023
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1-2
Continuous Blood Lactate and Potassium Monitoring via Intravascular Catheter Fiber Optic Sensors
Fiber optic sensors were integrated into intravascular catheters for continuous monitoring of blood lactate and potassium levels. Sensors showed promising results in an ex vivo flow circuit, demonstrating a strong correlation with blood gas analysis values. This has the potential to enhance clinical decision-making.
- 12 November 2023
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1-2
Continuous Blood Lactate and Potassium Monitoring via Intravascular Catheter Fiber Optic Sensors
Fiber optic sensors were integrated into intravascular catheters for continuous monitoring of blood lactate and potassium levels. Sensors showed promising results in an ex vivo flow circuit, demonstrating a strong correlation with blood gas analysis values. This has the potential to enhance clinical decision-making.
- Open Access
- 27 April 2023
- Published by Elsevier in American Journal of Transplantation
- Vol. 23 (8) , 1241-1255
Heart transplantation from donation after circulatory death: Impact on waitlist time and transplant rate
- 27 April 2023
- Published by Elsevier in American Journal of Transplantation
- Vol. 23 (8) , 1241-1255
Open AccessHeart transplantation from donation after circulatory death: Impact on waitlist time and transplant rate
- Open Access
- 24 April 2023
- Published by Wiley in Advanced Science
- Vol. 10 (18) , e2207455
A Clinical‐Scale Microfluidic Respiratory Assist Device with 3D Branching Vascular Networks
Recent global events such as COVID‐19 pandemic amid rising rates of chronic lung diseases highlight the need for safer, simpler, and more available treatments for respiratory failure, with increasing interest in extracorporeal membrane oxygenation (ECMO). A key factor limiting use of this technology is the complexity of the blood circuit, resulting in clotting and bleeding and necessitating treatment in specialized care centers. Microfluidic oxygenators represent a promising potential solution, but have not reached the scale or performance required for comparison with conventional hollow fiber membrane oxygenators (HFMOs). Here the development and demonstration of the first microfluidic respiratory assist device at a clinical scale is reported, demonstrating efficient oxygen transfer at blood flow rates of 750 mL min⁻1, the highest ever reported for a microfluidic device. The central innovation of this technology is a fully 3D branching network of blood channels mimicking key features of the physiological microcirculation by avoiding anomalous blood flows that lead to thrombus formation and blood damage in conventional oxygenators. Low, stable blood pressure drop, low hemolysis, and consistent oxygen transfer, in 24‐hour pilot large animal experiments are demonstrated – a key step toward translation of this technology to the clinic for treatment of a range of lung diseases.
- 24 April 2023
- Published by Wiley in Advanced Science
- Vol. 10 (18) , e2207455
Open AccessA Clinical‐Scale Microfluidic Respiratory Assist Device with 3D Branching Vascular Networks
Recent global events such as COVID‐19 pandemic amid rising rates of chronic lung diseases highlight the need for safer, simpler, and more available treatments for respiratory failure, with increasing interest in extracorporeal membrane oxygenation (ECMO). A key factor limiting use of this technology is the complexity of the blood circuit, resulting in clotting and bleeding and necessitating treatment in specialized care centers. Microfluidic oxygenators represent a promising potential solution, but have not reached the scale or performance required for comparison with conventional hollow fiber membrane oxygenators (HFMOs). Here the development and demonstration of the first microfluidic respiratory assist device at a clinical scale is reported, demonstrating efficient oxygen transfer at blood flow rates of 750 mL min⁻1, the highest ever reported for a microfluidic device. The central innovation of this technology is a fully 3D branching network of blood channels mimicking key features of the physiological microcirculation by avoiding anomalous blood flows that lead to thrombus formation and blood damage in conventional oxygenators. Low, stable blood pressure drop, low hemolysis, and consistent oxygen transfer, in 24‐hour pilot large animal experiments are demonstrated – a key step toward translation of this technology to the clinic for treatment of a range of lung diseases.
- Open Access
- 24 April 2023
- Published by Cambridge University Press (CUP) in Journal of Clinical and Translational Science
- Vol. 7 (s1) , 99
332 Role of Kynurenine/Tryptophan Ratio in Kidney-Lung crosstalk in two porcine trauma-induced multi-organ injury models
OBJECTIVES/GOALS: Multiple Organ Failure, often precipitated by Acute Lung Injury, is a life-threatening condition that causes death in military and civilian life. Furthermore, Acute Kidney Injury is very common, increasing morbidity and mortality rates. Therefore, understanding the molecular difference between survivors and non-survivors is urgently needed. METHODS/STUDY POPULATION: A 24-hour unilateral pulmonary contusion porcine model (pneumonectomy) of trauma-induced Multiple Organ Failure (MOF) model (n=17) and separate 48-hour polytrauma injury of bilateral pulmonary contusion, traumatic brain injury, and hemorrhage (polytrauma) MOF model (n=26) was developed at Dr. Batchinsky's AREVA laboratory. Serum was assayed at baseline and 3h or 6h post-trauma for amino acid metabolites using the Zip-Chip platform for mass spectrometry. The IDO1 enzyme activity assay kit (ab235936) was used to measure IDO1 enzyme activity in the tissue. Mass Spectrometry Imaging (MSI) was employed to frozen kidney tissues. Tissues were sectioned to 10- micron thickness. For MSI, the DAN matrix was utilized, and MALDI-MSI images were processed and obtained from METASPACE and SCILS software. RESULTS/ANTICIPATED RESULTS: In the pneumonectomy model, 10 survived, 7 died, and in the polytrauma group, 13 survived, and 13 died. In the pneumonectomy model, there was a significant increase in the serum kynurenine/tryptophan (KYN/TRP) ratio in the non-survivors 3h post-injury. A similar pattern was found in the validation group, which showed a significant increase in the KYN/TRP ratio at 6h post-trauma in non-survivors from the polytrauma model. There was a significant increase in IDO1 enzyme activity in non-survivor kidney tissues and a downregulation of tryptophan (TRP) metabolite in the kidney section in the non-survivor group post-trauma. DISCUSSION/SIGNIFICANCE: An increase in the KYN/TRP ratio post-trauma identified the pigs that suffered early mortality. A decrease in TRP metabolite and an increase in IDO1 enzyme activity in the kidney could contribute to an increase in KYN in the non-survivors. As a result, focusing on therapeutics targeting the KYN/TRP to reduce the incidence and severity of MOF is warranted.
- 24 April 2023
- Published by Cambridge University Press (CUP) in Journal of Clinical and Translational Science
- Vol. 7 (s1) , 99
Open Access332 Role of Kynurenine/Tryptophan Ratio in Kidney-Lung crosstalk in two porcine trauma-induced multi-organ injury models
OBJECTIVES/GOALS: Multiple Organ Failure, often precipitated by Acute Lung Injury, is a life-threatening condition that causes death in military and civilian life. Furthermore, Acute Kidney Injury is very common, increasing morbidity and mortality rates. Therefore, understanding the molecular difference between survivors and non-survivors is urgently needed. METHODS/STUDY POPULATION: A 24-hour unilateral pulmonary contusion porcine model (pneumonectomy) of trauma-induced Multiple Organ Failure (MOF) model (n=17) and separate 48-hour polytrauma injury of bilateral pulmonary contusion, traumatic brain injury, and hemorrhage (polytrauma) MOF model (n=26) was developed at Dr. Batchinsky's AREVA laboratory. Serum was assayed at baseline and 3h or 6h post-trauma for amino acid metabolites using the Zip-Chip platform for mass spectrometry. The IDO1 enzyme activity assay kit (ab235936) was used to measure IDO1 enzyme activity in the tissue. Mass Spectrometry Imaging (MSI) was employed to frozen kidney tissues. Tissues were sectioned to 10- micron thickness. For MSI, the DAN matrix was utilized, and MALDI-MSI images were processed and obtained from METASPACE and SCILS software. RESULTS/ANTICIPATED RESULTS: In the pneumonectomy model, 10 survived, 7 died, and in the polytrauma group, 13 survived, and 13 died. In the pneumonectomy model, there was a significant increase in the serum kynurenine/tryptophan (KYN/TRP) ratio in the non-survivors 3h post-injury. A similar pattern was found in the validation group, which showed a significant increase in the KYN/TRP ratio at 6h post-trauma in non-survivors from the polytrauma model. There was a significant increase in IDO1 enzyme activity in non-survivor kidney tissues and a downregulation of tryptophan (TRP) metabolite in the kidney section in the non-survivor group post-trauma. DISCUSSION/SIGNIFICANCE: An increase in the KYN/TRP ratio post-trauma identified the pigs that suffered early mortality. A decrease in TRP metabolite and an increase in IDO1 enzyme activity in the kidney could contribute to an increase in KYN in the non-survivors. As a result, focusing on therapeutics targeting the KYN/TRP to reduce the incidence and severity of MOF is warranted.